Furthermore, when compared to the praziquantel treatment group, the quercetin group displayed a notable reduction in the expression of c-jun mRNA, as well as type I and III collagen, suggesting that quercetin may potentially exert a superior long-term effect on schistosomiasis-induced liver fibrosis compared to praziquantel. The gene discussed is JUN; the disease is schistosomiasis.